These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17990355)

  • 1. Novel translational strategies in colorectal cancer research.
    Gil-Bazo I
    World J Gastroenterol; 2007 Nov; 13(44):5902-10. PubMed ID: 17990355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in colorectal cancer.
    Markman B; Rodríguez-Freixinos V; Tabernero J
    Clin Transl Oncol; 2010 Apr; 12(4):261-70. PubMed ID: 20462835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular biology in clinical cancer research: the example of digestive cancers].
    Lièvre A; Laurent-Puig P
    Rev Epidemiol Sante Publique; 2005 Jun; 53(3):267-82. PubMed ID: 16227914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying Genomics and Proteomics in Translational Surgical Oncology Research.
    Gemoll T; Meyer R; Habermann JK
    Eur Surg Res; 2015; 55(3):184-97. PubMed ID: 26339997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.
    Siravegna G; Bardelli A
    Mol Oncol; 2016 Mar; 10(3):475-80. PubMed ID: 26774880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special Issue on Molecular and Translational Research on Colorectal Cancer 2.0.
    Passardi A; Scarpi E; Ulivi P
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
    de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
    Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Biomarkers and Targeted Therapy Into Colorectal Cancer Management.
    Lieu CH; Corcoran RB; Overman MJ
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():207-215. PubMed ID: 31099678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Omics of Metastatic Colorectal Cancer.
    Li C; Sun YD; Yu GY; Cui JR; Lou Z; Zhang H; Huang Y; Bai CG; Deng LL; Liu P; Zheng K; Wang YH; Wang QQ; Li QR; Wu QQ; Liu Q; Shyr Y; Li YX; Chen LN; Wu JR; Zhang W; Zeng R
    Cancer Cell; 2020 Nov; 38(5):734-747.e9. PubMed ID: 32888432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
    Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting FGF receptors in colorectal cancer: from bench side to bed side.
    Abdel-Rahman O
    Future Oncol; 2015; 11(9):1373-9. PubMed ID: 25952783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical Practice.
    Maurel J; Postigo A
    Curr Cancer Drug Targets; 2015; 15(8):703-15. PubMed ID: 26452385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational research in prognostic profiling in colorectal cancer.
    de Noo ME; Liefers GJ; Tollenaar RA
    Dig Surg; 2005; 22(4):276-81. PubMed ID: 16174984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. crcTRP: a translational research platform for colorectal cancer.
    Deng N; Zheng L; Liu F; Wang L; Duan H
    Comput Math Methods Med; 2013; 2013():930362. PubMed ID: 23431356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
    Daher A; de Groot J
    Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic methodologies and their application in colorectal cancer research.
    Ikonomou G; Samiotaki M; Panayotou G
    Crit Rev Clin Lab Sci; 2009; 46(5-6):319-42. PubMed ID: 19958217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving forward in colorectal cancer research, what proteomics has to tell.
    Bitarte N; Bandrés E; Zárate R; Ramirez N; Garcia-Foncillas J
    World J Gastroenterol; 2007 Nov; 13(44):5813-21. PubMed ID: 17990347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating pEGFR is a candidate response biomarker of cetuximab therapy in colorectal cancer.
    Katsila T; Juliachs M; Gregori J; Macarulla T; Villarreal L; Bardelli A; Torrance C; Elez E; Tabernero J; Villanueva J
    Clin Cancer Res; 2014 Dec; 20(24):6346-56. PubMed ID: 25324142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From genome to proteome in tumor profiling: molecular events in colorectal cancer genesis.
    Habermann JK; Roblick UJ; Upender M; Ried T; Auer G
    Adv Exp Med Biol; 2006; 587():161-77. PubMed ID: 17163165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.